HN2001000042A - TYPE 1 SODIUM-HYDROGEN EXCHANGER INHIBITOR - Google Patents

TYPE 1 SODIUM-HYDROGEN EXCHANGER INHIBITOR

Info

Publication number
HN2001000042A
HN2001000042A HN2001000042A HN2001000042A HN2001000042A HN 2001000042 A HN2001000042 A HN 2001000042A HN 2001000042 A HN2001000042 A HN 2001000042A HN 2001000042 A HN2001000042 A HN 2001000042A HN 2001000042 A HN2001000042 A HN 2001000042A
Authority
HN
Honduras
Prior art keywords
sodium
type
hydrogen exchanger
exchanger inhibitor
inhibitor
Prior art date
Application number
HN2001000042A
Other languages
Spanish (es)
Inventor
Weichao George Chen
Eric David Cox
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of HN2001000042A publication Critical patent/HN2001000042A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treatment Of Water By Ion Exchange (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UN INHIBIDOR DEL INTERCAMBIADOR DE SODIO-HIDROGENO DE TIPO 1 (NHE-1).THIS INVENTION REFERS TO A TYPE 1 SODIUM-HYDROGEN EXCHANGER INHIBITOR (NHE-1).

HN2001000042A 2000-04-28 2001-03-06 TYPE 1 SODIUM-HYDROGEN EXCHANGER INHIBITOR HN2001000042A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20043200P 2000-04-28 2000-04-28

Publications (1)

Publication Number Publication Date
HN2001000042A true HN2001000042A (en) 2001-07-09

Family

ID=22741697

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2001000042A HN2001000042A (en) 2000-04-28 2001-03-06 TYPE 1 SODIUM-HYDROGEN EXCHANGER INHIBITOR

Country Status (40)

Country Link
EP (1) EP1276737A1 (en)
JP (1) JP2003531900A (en)
KR (1) KR20020093079A (en)
CN (1) CN1225466C (en)
AP (1) AP2002002651A0 (en)
AR (1) AR028375A1 (en)
AU (1) AU2001235896A1 (en)
BG (1) BG107139A (en)
BR (1) BR0110268A (en)
CA (1) CA2407535A1 (en)
CO (1) CO5221125A1 (en)
CR (1) CR6797A (en)
CZ (1) CZ20023408A3 (en)
DZ (1) DZ3310A1 (en)
EA (1) EA004882B1 (en)
EE (1) EE200200615A (en)
GT (1) GT200100064A (en)
HN (1) HN2001000042A (en)
HR (1) HRP20020851A2 (en)
HU (1) HUP0300651A2 (en)
IL (1) IL152075A0 (en)
IS (2) IS6567A (en)
MA (1) MA26897A1 (en)
MX (1) MXPA02010600A (en)
MY (1) MY133842A (en)
NO (1) NO20025132L (en)
NZ (1) NZ521348A (en)
OA (1) OA12256A (en)
PA (1) PA8513301A1 (en)
PE (1) PE20011270A1 (en)
PL (1) PL357765A1 (en)
SK (1) SK14872002A3 (en)
SV (1) SV2002000418A (en)
TN (1) TNSN01065A1 (en)
TR (1) TR200202439T2 (en)
UA (1) UA73348C2 (en)
UY (1) UY26680A1 (en)
WO (1) WO2001083470A1 (en)
YU (1) YU79602A (en)
ZA (1) ZA200208605B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1355899A1 (en) * 2001-01-31 2003-10-29 Pfizer Products Inc. Ethanolates of sodium-hydrogen exchanger type-1 inhibitor
AU2002337460A1 (en) * 2001-12-19 2003-06-30 Pfizer Products Inc. Methods for preparing sodium-hydrogen exchanger type-1 inhibitors
BR0309707A (en) * 2002-05-02 2005-02-09 Pfizer Prod Inc Treatment of diabetes and diabetic complications with nhe-1 inhibitors
FR2840302B1 (en) * 2002-06-03 2004-07-16 Aventis Pharma Sa ISOINDOLONE DERIVATIVES, PREPARATION METHOD AND INTERMEDIARY THEREOF AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME
ES2220185B1 (en) * 2002-07-16 2006-04-01 Consejo Sup. De Investig. Cientificas NEW INHIBITOR PEPTIDE OF THE NA + / H + EXCHANGER (PINHE), AND ITS APPLICATIONS.
WO2004073628A2 (en) * 2003-02-14 2004-09-02 Smithkline Beecham Corporation Novel compounds
RU2518741C1 (en) * 2013-03-22 2014-06-10 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" MEDICATION, INHIBITING Na+/H+-EXCHANGE, AND HALOGENIDES OF 1-DIALKYLAMINOETHYL-3-[SUBSTITUTED(DISUBSTITUTED)PHENACYL]-2-AMINOBENZIMIDAZOLIUM

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1454902A1 (en) * 1998-02-27 2004-09-08 Pfizer Products Inc. N- (substituted five-membered di-or triaza diunsaturated ring)carbonyl guanidine derivateives for the treatment of ischemia

Also Published As

Publication number Publication date
OA12256A (en) 2003-11-06
HUP0300651A2 (en) 2003-07-28
TR200202439T2 (en) 2003-02-21
CZ20023408A3 (en) 2004-01-14
IL152075A0 (en) 2003-05-29
CO5221125A1 (en) 2002-11-28
AR028375A1 (en) 2003-05-07
EP1276737A1 (en) 2003-01-22
UY26680A1 (en) 2001-12-28
PL357765A1 (en) 2004-07-26
MXPA02010600A (en) 2003-03-10
MY133842A (en) 2007-11-30
AU2001235896A1 (en) 2001-11-12
CR6797A (en) 2004-05-17
YU79602A (en) 2006-05-25
NO20025132D0 (en) 2002-10-25
EA004882B1 (en) 2004-08-26
KR20020093079A (en) 2002-12-12
GT200100064A (en) 2002-03-22
NO20025132L (en) 2002-12-12
EE200200615A (en) 2004-04-15
CN1426404A (en) 2003-06-25
MA26897A1 (en) 2004-12-20
WO2001083470A1 (en) 2001-11-08
BG107139A (en) 2003-07-31
EA200201023A1 (en) 2003-02-27
TNSN01065A1 (en) 2005-11-10
CN1225466C (en) 2005-11-02
PA8513301A1 (en) 2003-09-05
CA2407535A1 (en) 2001-11-08
HRP20020851A2 (en) 2005-02-28
SV2002000418A (en) 2002-07-03
DZ3310A1 (en) 2001-11-07
JP2003531900A (en) 2003-10-28
ZA200208605B (en) 2003-10-24
NZ521348A (en) 2004-09-24
IS6567A (en) 2002-09-24
PE20011270A1 (en) 2001-12-12
UA73348C2 (en) 2005-07-15
AP2002002651A0 (en) 2002-12-31
IS6588A (en) 2002-10-21
SK14872002A3 (en) 2004-03-02
BR0110268A (en) 2003-12-30

Similar Documents

Publication Publication Date Title
HN1999000155A (en) 4-CARBOXYAMINO-2-METHYL-1,2,3,4-TETRAHYDROKINOLINS
HN2001000139A (en) STABILIZED INTERLEUQUINA 2
HN1999000154A (en) 1,2,3,4 TETRAHIDROQUINOLINAS 2 SUBSTITUTED 4 - CARBOXIAMINO SUBSTITUTED.
HN1998000175A (en) IMIDAZOTRIAZININS
HN1999000125A (en) NEW SUBSTITUTED DERIVATIVES OF PIRAZOLE
HN2001000042A (en) TYPE 1 SODIUM-HYDROGEN EXCHANGER INHIBITOR
HN1998000045A (en) PHARMACEUTICAL COMPOSITIONS
HN2000000234A (en) PROASA FINDER TEAM
HN2000000230A (en) SODIUM EXCHANGER INHIBITOR CRYSTALS - TYPE 1 HYDROGEN.
DE60115933D1 (en) BIOZIDE COMPOSITION
HN2000000062A (en) SUBSTITUTED BENZOLACTAMA COMPOUNDS
HN1999000038A (en) NEW FUNGICIDE COMPOUNDS
HN2000000247A (en) COMBINATION CHEMOTHERAPY
HN2000000188U (en) COMBINED PLOW
HN2000000191A (en) THE TRICICLIC POLI INHIBITORS (ADP-RIBOSA)
HN2000000276A (en) THIAZOLILAMIDE DERIVATIVES
HN2000000172A (en) POLYMORPHIC SALT
HN2000000205A (en) PURINA DERIVATIVES
HN1999000181A (en) ANTIPARASITIC FORMULATIONS.
HN2000000223A (en) NEW USEFUL BIARILETER DERIVATIVES AS MONOAMINE RECOVERY INHIBITORS
HN2000000277A (en) INHIBITORS OF PROTEINASE C OF PROCOLAGEN.
HN1997000147A (en) PROCEDURES FOR SUBSTITUTED PIRIDINES
HN2000000015A (en) DANNILMA ELECTRONIC SYSTEM
CR6753A (en) SECURITY BAR TRANSFER MECHANISM ASSEMBLY
HN1998000134A (en) FUNGICIDES